EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIES

Cutaneous leishmaniasis is endemic in 88 different countries. There are an estimated 1.5 million new cases each year, with over 90% occurring in Afghanistan, Algeria, Iran, Iraq, Saudi Arabia, Syria (Old World) and in Brazil and Peru (New World). Miltefosine is effective in vitro and in vivo against...

Full description

Bibliographic Details
Main Authors: J. Esmaeili, M. Mohebali, G. H. Edrissian, S. M. Rezayat, M. Ghazi-Khansari, S. Charehdar
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2008-06-01
Series:Acta Medica Iranica
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/8827.pdf&manuscript_id=8827